Follow
Fabrizio De Benedetti
Fabrizio De Benedetti
Head, Division of Rheumatology, Ospedale Bambino Gesù, Roma
Verified email at opbg.net
Title
Cited by
Cited by
Year
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis
F De Benedetti, HI Brunner, N Ruperto, A Kenwright, S Wright, I Calvo, ...
New England Journal of Medicine 367 (25), 2385-2395, 2012
9412012
2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of …
A Ravelli, F Minoia, S Davì, AC Horne, F Bovis, A Pistorio, M Aricò, ...
Annals of the Rheumatic Diseases 75 (3), 481-489, 2016
8292016
Interleukin 6 is required for the development of collagen-induced arthritis
T Alonzi, E Fattori, D Lazzaro, P Costa, L Probert, G Kollias, ...
The Journal of experimental medicine 187 (4), 461-468, 1998
8051998
On the alert for cytokine storm: immunopathology in COVID‐19
LA Henderson, SW Canna, GS Schulert, S Volpi, PY Lee, KF Kernan, ...
Arthritis & rheumatology 72 (7), 1059-1063, 2020
7392020
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation.
F De Benedetti, T Alonzi, A Moretta, D Lazzaro, P Costa, V Poli, A Martini, ...
The Journal of clinical investigation 99 (4), 643-650, 1997
6081997
Translating IL-6 biology into effective treatments
EH Choy, F De Benedetti, T Takeuchi, M Hashizume, MR John, ...
Nature Reviews Rheumatology 16 (6), 335-345, 2020
4742020
Correlation of serum interleukin‐6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis
F de Benedetti, M Massa, P Robbioni, A Ravelli, GR Burgio, A Martini
Arthritis & Rheumatism: Official Journal of the American College of …, 1991
4371991
Canakinumab for the treatment of autoinflammatory recurrent fever syndromes
F De Benedetti, M Gattorno, J Anton, E Ben-Chetrit, J Frenkel, ...
New England Journal of Medicine 378 (20), 1908-1919, 2018
4262018
Macrophage activation syndrome in the era of biologic therapy
AA Grom, AC Horne, F De Benedetti
Nature Reviews Rheumatology 12 (5), 259-268, 2016
3842016
Emapalumab in children with primary hemophagocytic lymphohistiocytosis
F Locatelli, MB Jordan, C Allen, S Cesaro, C Rizzari, A Rao, B Degar, ...
New England Journal of Medicine 382 (19), 1811-1822, 2020
3742020
Impaired skeletal development in interleukin‐6–transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system
F De Benedetti, N Rucci, A Del Fattore, B Peruzzi, R Paro, M Longo, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2006
3542006
Classification criteria for autoinflammatory recurrent fevers
M Gattorno, M Hofer, S Federici, F Vanoni, F Bovis, I Aksentijevich, ...
Annals of the rheumatic diseases 78 (8), 1025-1032, 2019
3382019
Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile …
R Donn, Z Alourfi, F De Benedetti, C Meazza, E Zeggini, M Lunt, ...
Arthritis & Rheumatism 46 (9), 2402-2409, 2002
3322002
Treating juvenile idiopathic arthritis to target: recommendations of an international task force
A Ravelli, A Consolaro, G Horneff, RM Laxer, DJ Lovell, NM Wulffraat, ...
Annals of the rheumatic diseases 77 (6), 819-828, 2018
3062018
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
HI Brunner, N Ruperto, Z Zuber, C Keane, O Harari, A Kenwright, P Lu, ...
Annals of the rheumatic diseases 74 (6), 1110-1117, 2015
3042015
Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis.
F De Benedetti, M Massa, P Pignatti, S Albani, D Novick, A Martini
The Journal of clinical investigation 93 (5), 2114-2119, 1994
2801994
Inhibition of natural killer cell cytotoxicity by interleukin‐6: implications for the pathogenesis of macrophage activation syndrome
L Cifaldi, G Prencipe, I Caiello, C Bracaglia, F Locatelli, F De Benedetti, ...
Arthritis & rheumatology 67 (11), 3037-3046, 2015
2712015
Functional and prognostic relevance of the− 173 polymorphism of the macrophage migration inhibitory factor gene in systemic‐onset juvenile idiopathic arthritis
F De Benedetti, C Meazza, M Vivarelli, F Rossi, A Pistorio, R Lamb, ...
Arthritis & Rheumatism 48 (5), 1398-1407, 2003
2512003
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
SJ Vastert, R Van Wijk, LE D’Urbano, KMK De Vooght, W De Jager, ...
Rheumatology 49 (3), 441-449, 2010
2492010
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009
DE Furst, EC Keystone, R Fleischmann, P Mease, FC Breedveld, ...
Annals of the Rheumatic Diseases 69 (Suppl 1), i2-i29, 2010
2472010
The system can't perform the operation now. Try again later.
Articles 1–20